SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-12-001199
Filing Date
2012-09-18
Accepted
2012-09-18 17:25:09
Documents
5
Period of Report
2012-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrx_8k.htm 8-K 38978
2 EXHIBIT 99.1 - PRESS RELEASE DATED SEPTEMBER 13, 2012 ex99-1.htm EX-99.1 11149
3 EXHIBIT 99.2 - PRESS RELEASE DATED SEPTEMBER 18, 2012 ex99-2.htm EX-99.2 7676
4 ex99-01.jpg GRAPHIC 8351
5 ex99-02.jpg GRAPHIC 3405
  Complete submission text file 0001341004-12-001199.txt   75670
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121098113
SIC: 2834 Pharmaceutical Preparations